Takeda | 4502 - Cost Of Sales

Stock Price
5,289.00
Daily Change
71.00 1.36%
Monthly
-7.42%
Yearly
22.06%
Q2 Forecast
5,127.47

Takeda reported JPY401.15B in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Astellas Pharma JPY 129.43B 19.7B Mar/2026
Chugai Pharma JPY 92.79B 5.23B Mar/2026
Daiichi Sankyo JPY 118.28B 37.7B Dec/2025
Eisai JPY 51.08B 5.56B Dec/2025
Kyowa Hakko Kirin JPY 37.87B 9.67B Dec/2025
M3 JPY 45.54B 2.27B Dec/2025
Otsuka Holdings JPY 192.74B 11.78B Dec/2025
Shionogi JPY 25.65B 8.23B Dec/2025
Sumitomo Dainippon JPY 45.59B 1.48B Sep/2025
Takeda JPY 401.15B 184.07B Dec/2025
Terumo JPY 143.44B 15.47B Dec/2025